tradingkey.logo
tradingkey.logo
Search

Altimmune Inc

ALT
Add to Watchlist
3.040USD
-0.150-4.70%
Close 09-24 16:00(ET)
591.19MMarket Cap
LossP/E TTM
After-hours 19:45 (ET)3.060USD+0.015+0.49%

ALT Financials

See Altimmune Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
591.19M
Dividend TTM
0.00
P/E TTM
-3.30
EPS TTM
-0.92
Revenue
41.00K
Net Profit
-95.06M
ROE
-42.75%
ROA
-36.96%

Altimmune Inc Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
-0.12/-0.14
Revenue / Forecast
0.00/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
54.72%-0.12
30.04%-0.18
20.55%-0.26
33.84%-0.21
21.76%-0.27
24.80%-0.26
39.83%-0.33
16.61%-0.32
-9.65%-0.35
13.97%-0.34
---0.54
---0.39
---0.32
---0.40
----
---1.37
----
----
----
----
Revenue
-100.00%0.00
-100.00%0.00
420.00%26.00K
0.00%5.00K
0.00%5.00K
0.00%5.00K
-86.49%5.00K
-98.62%5.00K
-16.67%5.00K
-76.19%5.00K
133.64%37.00K
18000.00%362.00K
-25.00%6.00K
-34.38%21.00K
-103.36%-110.00K
-98.73%2.00K
-94.19%8.00K
-96.18%32.00K
41.72%3.28M
-94.64%157.56K
Net Profit
-3.07%-22.82M
-15.26%-22.56M
-18.02%-27.36M
16.77%-19.01M
10.12%-22.15M
19.75%-19.57M
26.74%-23.18M
-10.52%-22.84M
-53.42%-24.64M
-21.52%-24.39M
---31.64M
12.10%-20.67M
20.12%-16.06M
-3.31%-20.07M
----
29.83%-23.52M
19.01%-20.11M
-30.72%-19.43M
-124.91%-23.89M
-88.58%-33.51M
Net Margin
----
----
77.30%-105223.08%
16.77%-380280.00%
10.12%-442920.00%
19.75%-391500.00%
-442.12%-463600.00%
-7901.44%-456900.00%
-84.10%-492800.00%
-410.39%-487880.00%
---85516.22%
---5710.22%
---267683.33%
---95590.48%
----
---150126.19%
----
----
----
----
Gross Margin
----
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
--100.00%
----
----
----
----
Debt to assets ratio
-12.48%6.59%
--10.28%
--12.25%
--6.61%
--7.53%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
-100.00%0.00
-100.00%0.00
420.00%26.00K
0.00%5.00K
0.00%5.00K
0.00%5.00K
-86.49%5.00K
-98.62%5.00K
-16.67%5.00K
-76.19%5.00K
133.64%37.00K
18000.00%362.00K
-25.00%6.00K
-34.38%21.00K
-103.36%-110.00K
-98.73%2.00K
-94.19%8.00K
-96.18%32.00K
41.72%3.28M
-94.64%157.56K
Operating profit
-14.43%-26.23M
-11.13%-24.24M
-16.19%-28.89M
15.78%-20.86M
14.29%-22.92M
18.58%-21.82M
-17.27%-24.87M
-9.88%-24.77M
-48.53%-26.75M
-23.14%-26.79M
8.18%-21.20M
8.94%-22.54M
11.71%-18.01M
-11.59%-21.76M
-11.65%-23.09M
25.46%-24.75M
-21.45%-20.39M
-31.20%-19.50M
-92.42%-20.68M
-81.20%-33.20M
Net Profit
-3.07%-22.82M
-15.26%-22.56M
-18.02%-27.36M
16.77%-19.01M
10.12%-22.15M
19.75%-19.57M
26.74%-23.18M
-10.52%-22.84M
-53.42%-24.64M
-21.52%-24.39M
---31.64M
12.10%-20.67M
20.12%-16.06M
-3.31%-20.07M
----
29.83%-23.52M
19.01%-20.11M
-30.72%-19.43M
-124.91%-23.89M
-88.58%-33.51M
Current assets
77.69%334.81M
115.56%334.68M
102.68%278.19M
48.61%216.62M
10.07%188.42M
-17.20%155.26M
-34.52%137.25M
-4.71%145.76M
0.98%171.19M
8.32%187.51M
8.72%209.63M
-27.51%152.96M
-13.28%169.53M
-9.41%173.11M
-5.54%192.81M
-3.33%211.00M
-18.07%195.50M
-22.06%191.09M
-11.35%204.13M
0.06%218.26M
Total current liabilities
35.59%12.50M
15.56%11.32M
43.27%15.00M
45.94%12.61M
-39.16%9.22M
-13.54%9.80M
-13.79%10.47M
-27.23%8.64M
32.51%15.15M
-24.20%11.33M
-28.80%12.14M
-24.59%11.87M
-17.39%11.44M
-21.82%14.95M
-6.69%17.05M
-17.70%15.74M
52.21%13.85M
94.67%19.12M
52.04%18.28M
203.91%19.13M
Total assets
176.97%527.21M
113.42%335.63M
100.95%279.93M
47.74%218.45M
9.81%190.35M
-16.51%157.26M
-33.87%139.31M
-11.23%147.86M
-5.44%173.35M
0.68%188.36M
1.79%210.64M
-26.06%166.57M
-12.67%183.32M
-9.03%187.08M
-5.45%206.93M
-4.91%225.28M
-18.41%209.91M
-22.17%205.66M
-10.71%218.86M
1.68%236.91M
Total liabilities
82.88%53.00M
241.98%51.64M
248.38%55.04M
126.73%32.85M
39.24%28.98M
-2.08%15.10M
-4.49%15.80M
-10.44%14.49M
33.41%20.82M
-20.31%15.42M
-23.55%16.54M
-20.11%16.18M
1.50%15.60M
-6.93%19.35M
9.65%21.64M
-26.75%20.25M
-3.83%15.37M
16.72%20.79M
2.55%19.73M
-16.96%27.64M
Total equity
193.87%474.21M
99.76%283.99M
82.09%224.89M
39.16%185.60M
5.79%161.37M
-17.80%142.16M
-36.37%123.51M
-11.32%133.38M
-9.05%152.53M
3.10%172.94M
4.75%194.10M
-26.65%150.40M
-13.79%167.71M
-9.27%167.73M
-6.95%185.29M
-2.02%205.03M
-19.37%194.53M
-24.98%184.87M
-11.84%199.13M
4.79%209.26M
Net operating income
-25.17%-24.22M
-24.36%-20.94M
-6.48%-19.45M
56.13%-11.90M
-6.86%-19.35M
-2.95%-16.84M
-10.48%-18.27M
-32.37%-27.12M
6.58%-18.11M
15.72%-16.36M
4.47%-16.53M
-36.13%-20.49M
-16.04%-19.38M
-43.48%-19.41M
21.22%-17.31M
15.33%-15.05M
11.74%-16.70M
30.88%-13.53M
-65.38%-21.97M
-87.01%-17.78M
Net investment
-319.02%-221.44M
27.66%-3.69M
-680.68%-79.16M
-12553.79%-149.32M
2835.58%101.11M
87.09%-5.10M
271.28%13.63M
-72.76%1.20M
-192.70%-3.70M
-397.11%-39.52M
-911.31%-7.96M
117.33%4.40M
108.14%3.99M
147900.00%13.30M
-96.06%981.00K
-237.97%-25.40M
-295.27%-48.97M
-100.05%-9.00K
167.21%24.87M
138.45%18.41M
Net financing
304.01%211.07M
130.00%78.47M
704.46%81.13M
14692.86%39.35M
113673.91%52.24M
13172.41%34.12M
-86.14%10.09M
-54.76%266.00K
-100.35%-46.00K
13.58%-261.00K
169295.35%72.75M
-98.17%588.00K
-39.47%13.06M
-109.49%-302.00K
-100.34%-43.00K
25663.21%32.06M
19.78%21.58M
-90.76%3.18M
-44.79%12.54M
-99.91%124.44K

FAQs

What is the total revenue of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its total revenue reached 41.00K, with a year-on-year change of 20.00K.

What are the current assets of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its current assets were 278.19M, with a year-on-year change of 102.68.

What are the total assets of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its total assets of Altimmune Inc were 279.93M, with a year-on-year change of 100.95.

What are the total liabilities of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its total liabilities of Altimmune Inc were 55.04M, with a year-on-year change of 248.38.

What is the total equity of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its total equity of Altimmune Inc was 224.89M, with a year-on-year change of 82.09.

What is the net operating income of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net operating income of Altimmune Inc was -94.49M, with a year-on-year change of 8.42.

What is the net investment of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net investment of Altimmune Inc was -132.47M, with a year-on-year change of -366.68.

What is the net financing of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net financing of Altimmune Inc was 206.84M, with a year-on-year change of 1959.36.

What is the Earnings Per Share (EPS) of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.00, with a year-on-year change of 25.32.

What is the net income of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net income was -88.09M, with a year-on-year change of 7.33.

What is the net margin of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net profit margin was -214860.98, with a year-on-year change of 54.79.

What is the Return on Equity (ROE) of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its Return on Equity (ROE) was -50.57, with a year-on-year change of 15.52.

What is the Return on Assets (ROA) of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its Return on Assets (ROA) was -42.03, with a year-on-year change of 22.64.

What is the operating profit of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its operating profit was -94.49M, with a year-on-year change of 8.42.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.